Aripiprazol na síndrome de tourette em adultos: relato de caso e revisão narrativa
DOI:
https://doi.org/10.25118/2763-9037.2019.v9.61Palavras-chave:
Síndrome de Tourette, aripiprazol, tratamentoResumo
A síndrome de Tourette é um distúrbio de movimento caracterizado por tiques motores e vocais que surgem na infância e na adolescência, com metade a dois terços dos casos remitindo ainda nessas fases. Persistindo mais raramente na idade adulta, apresenta um prognóstico reservado, com difícil controle dos sintomas. O presente artigo descreve o uso de aripiprazol no tratamento da síndrome de Tourette em um adulto do sexo masculino e faz uma revisão narrativa de literatura sobre as evidências atuais disponíveis com o uso desse medicamento.
Downloads
Métricas
Referências
Janik P, Szejko N. Aripiprazole in treatment of Gilles de la Tourett e syndrome – new therapeuti c opti on. Neurol Neurochir Pol. 2018;52:84-7.
Sallee F, Kohegyi E, Zhao J, McQuade R, Cox K, Sanchez R, et al. Randomized, double-blind, placebo-controlled trial demonstrates the effi cacy and safety of oral aripiprazole for the treatment of Tourett e’s disorder in children and adolescents. J Child Adolesc Psychopharmacol. 2017;27:771-81.
Gerasch S, Kanaan AS, Jakubovski E, Müller-Vahl KR. Aripiprazole improves associated comorbid conditi ons in additi on to ti cs in adult pati ents with Gilles de la Tourett e syndrome. Front Neurosci. 2016;10:416.
Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J. Update on the role of anti psychoti cs in the treatment of Tourett e syndrome. Neuropsychiatr Dis Treat. 2012;8:95-104.
Lavoie ME, O’Connor K. Toward a multi factorial concepti on of the Gilles de la Tourett e syndrome and persistent chronic ti c disorder. Brain Sci. 2017 Jun 2;7(6). pii: E61.
Budman CL. The role of atypical anti psychoti cs for treatment of Tourett e’s syndrome: an overview. Drugs. 2014;74:1177-93.
Bhati a M, Gautam P, Kaur J. Case report on Tourett e syndrome treated successfully with aripiprazole. Shanghai Arch Psychiatry. 2014;26:297-9.
Zheng W, Li XB, Xiang YQ, Zhong BL, Chiu HF, Ungvari GS, et al. Aripiprazole for Tourett e’s syndrome: a systemati c review and meta-analysis. Hum Psychopharmacol. 2016;31:11-8.
Wenzel C, Kleimann A, Bokemeyer S, Müller-Vahl KR. Aripiprazole for the treatment of Tourett e syndrome: a case series of 100 pati ents. J Clin Psychopharmacol. 2012;32:548-50.
Taskiran S, Tufan AE, Semerci B. Aripiprazole can a viable choice for persistant suppression of symptoms in managing chronic ti c disorders and Tourett e’s disorder through the life span: a case series. Klinik Psikofarmakol Bü lteni. 2016;26:181-5.
Yang C, Hao Z, Zhu C, Guo Q, Mu D, Zhang L. Interventi ons for ti c disorders: an overview of systemati c reviews and meta analyses. Neurosci Biobehav Rev. 2016;63:239-55.
Ghanizadeh A. Systemic review of aripiprazole for the treatment of children and adolescents with ti c disorders. Neurosciences (Riyadh). 2012;17:200-4.
Yang CS, Huang H, Zhang LL, Zhu CR, Guo Q. Aripiprazole for the treatment of ti c disorders in children: a systemati c review and meta-analysis. BMC Psychiatry. 2015;15:179.
Eddy CM, Rickards HE, Cavanna AE. Treatment strategies for ti cs in Tourett e syndrome. Ther Adv Neurol Disord. 2011;4:25-45.
Padala PR, Qadri SF, Madaan V. Aripiprazole for the treatment of Tourett e’s disorder. Prim Care Companion J Clin Psychiatry. 2005;7:296-9.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria permite que o (s) autor (es) mantenha(m) seus direitos autorais sem restrições. Atribuição-NãoComercial 4.0 Internacional (CC BY-NC 4.0) - Debates em Psiquiatria é regida pela licença CC-BY-NC
